1. 880PSubgroups analysis and circulating biomarkers evaluation of RESORT trial: A randomized phase II study in metastatic renal cell carcinoma (mRCC) patients (pts) to evaluate the efficacy of sorafenib after metastasectomy. (23rd October 2018) Authors: Procopio, G; Cognetti, F; Miceli, R; Milella, M; Mosca, A; Chiuri, V E; Bearz, A; Morelli, F; Ortega, C; Atzori, F; Passalacqua, R; Ratta, R; de Braud, F G M; Cappelletti, V; Verzoni, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB1125 Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models. (15th June 2017) Authors: Ceccarelli, F; Sciandrone, M; Perricone, C; Galvan, G; Morelli, F; Vicente, LN; Leccese, I; Massaro, L; Cipriano, E; Spinelli, FR; Alessandri, C; Valesini, G; Conti, F Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗